350 likes | 369 Views
This report presents an overview of the trends in NIH awards presented to members of the Association of Independent Research Institutes (AIRI) from 1950 to 2010. It includes information on funding rates, success rates, and characteristics of NIH-supported investigators. The report also analyzes the impact of the American Recovery and Reinvestment Act (ARRA) on NIH funding.
E N D
AIRI Statistics Trends In NIH AwardsPresented at Association of Independent Research Institutes 2009 Annual Meeting October 7, 2009 Seattle, Washington Robert F. MooreKatrina PearsonRobin M. Wagner, PhD, MS Reporting Branch, Division of Information ServicesOffice of Research Information SystemsOffice of Extramural Research/Office of the Director
Overview • Methods • Definitions • Policy Changes • NIH Budget Authority and American Recovery and Reinvestment Act (ARRA) • NIH Support to All Grantees and AIRI Members • Competing Applications, Funding and Success Rates • Characteristics of NIH-Supported Investigators • Summary
Methods • Data sources: President’s Budget and NIH systems • Fiscal years evaluated = 1950 - 2010 • Analyzed grants and contracts for current AIRI members • Exception: FY09 contracts data are excluded because they are not yet available • FY09 grants data are preliminary • ARRA excluded from all slides unless noted • Evaluated budget in terms of current dollars and constant dollars adjusted for inflation • Budget figures in current dollars unless otherwise stated • Analyzed and compared data on all NIH applicants and awardees to the subset from AIRI institutions
Definitions • New (Type 1) • Competing Continuation: Types 2, 4, and 9 • Resubmissions: Competing applications submitted to address concerns of previous application. Formerly known as amendments. • Revisions: Competing applications modifying existing awards to take advantage of new insights and discoveries. Formerly known as competing supplements.
Definitions – Standard Mechanisms Research Grants: R,P,M,S,K,U,G12,D42,DP1 and DP2 • Research Project Grants (RPGs): Includes the following selected Research Grant and Cooperative Agreement activities: R01, R03, R15, R21, R22, R23, R29, R33, R34, R35, R36, R37, R55, R56, RC1, P01, P42, PN1, U01, U19, UC1, NIGMS P41 • R01 Equivalent: R01, R29 and R37 • R21: Exploratory, novel studies that break new ground or extend previous discoveries toward new directions or applications, including high risk high reward studies.
Definitions Cont’d • Number of Applications: Total applications submitted for review, including resubmissions and revisions. Sometimes called workload • Success Rate: Indicates the percentage of reviewed RPG applications receiving funding computed on a fiscal year basis. It is determined by dividing the number of competing applications funded by the sum of the total number of competing applications reviewed and the number of funded carryovers. NOTE: Applications having one or more amendments in the same fiscal year are only counted once. Success rate computations exclude SBIR/STTRs • Funding Rate: The percentage of applicants funded in a fiscal year. An applicant is only counted once, regardless of the number of applications submitted
NIH Budget Authority, FYs 1983-2010 Constant Dollars and Inflation BRDPI* for 1983 = 100.0, FY 2010 = 293 *Includes ARRA
NIH ARRA Funding by Mechanism, FY 2009 Total Expected NIH Recovery Act Funding $10.4 Billion
ARRA Applications by Type, All Institutions vs. AIRI Members, FY 2009
Applications funded under ARRA by Type, All Institutions vs. AIRI Members, FY 2009
NIH Extramural Grant and R&D Contract Awards by Mechanism, FYs 1998, 2003 and 2008
NIH Extramural Grants and Contracts by Kind of Institution, FYs 1998, 2003 and 2008
NIH Extramural Grant and Contract Awards by Mechanism to AIRI Members, FY 1998, 2003 and 2008
NIH Grants and R&D Contracts Support to AIRI Members by Institutes and Centers, FY 2008
AIRI Awards as Percent of I/C Totals, FY 2008 Percent of NIH Grant R&D Contract Support to AIRI Members – 6.2 Percent
NIH Training and Research Career Awards to AIRI Members, FYs 1998, 2003 and 2008
NIH Competing R01 Equivalent Applications by Fiscal Year of Review Excludes ARRA Solicitations
NIH Competing R01 Equivalent Applications: Resubmissions as % of All Applications
NIH R01 Equivalent Applications by Submission Status and Award Type, Council Years 1990 – 2009 Excludes ARRA Solicitations
NIH Competing Research Project Applications by Council Year and ARRA Status Thousands
NIH Competing Research Project Applications by Council Year and Activity
Success Rates of NIH New Competing R01 Equivalent Awards: Originals and Resubmissions
Success Rates of NIH Competing Continuation R01 Equivalent, Original and Resubmitted Applications
NIH R01 Equivalent Research Project Applications and Awards from AIRI Members
Success Rates of Competing R01 Equivalent Applications: AIRI vs. All NIH Grantees
Number of First Time R01 Equivalent Awardees: AIRI v. Other Grantees, FYs 1998 – 2008
Average Age of Competing NIH R01 Equivalent Awardees: First time v. All, FYs 1970 – 2008
Funding Rates of R01 Equivalent Applications by Type and Age of Applicant, FY 2008
Number of R01 Equivalent Applicants by Type and Age of Applicant, FY 2008
Summary - I • American Recovery & Reinvestment Act of 2009 (ARRA) $10.4 billion total, $9.9 billion in extramural funding • Select recently peer reviewed highly meritorious research grant applications (R01s and others), that can be accomplished in 2 years or less. • Fund new research applications. • Accelerate the tempo of ongoing science through targeted supplements to current grants. • Support new types of activities such as the NIH Challenge Grant program that meet the goals of the ARRA. • $1 Billion extramural construction, repairs, and alterations in support of all NIH funded research institutions and $300 million for shared instrumentation and other capital equipment to support all NIH activities • ARRA funding changed a pattern of steady funding since the end of the doubling in FY 2003.
Summary -II • In FY 2008, AIRI members received over $1.4 billion in NIH extramural support including R&D contracts. • AIRI members continue to receive a steady percentage of the total NIH grant and contract budget (5.9 – 6.6 percent) • A smaller percent of NIH grant support is devoted to R01 equivalents in FY 2008 (46.7 percent) than in FY 1998 (56 percent). The data for AIRI Institutions is similar (59.9 percent in FY 1998, 46.6 percent in FY 2008) • In FY 2008, NCI and NIAID provided the largest amount of grant support to AIRI members ($355 million and $322 million , respectively). • The Office of Research on Women’s Health, Office of the Director and NHGRI all awarded more than 10 percent of their budgets to AIRI members.
Summary - III • Grants to AIRI cost more due to higher indirect costs. • The number of distinct R01 equivalent amended applications is increasing. Amendments have higher success rates than original applications, both for competing new and continuation R01 applications. • AIRI members had better success rates than the NIH average except in FY 2007. • The trend toward increasingly older first time investigators seems to have ended. The average age in FY 2008 was 42.5 years. • In FY 2008, younger applicants had higher success rates for new R01 equivalent awards than older groups, but this pattern was not observed for competing continuations.
Contacts Robert F. Moore Consultant, Reporting Branch Division of Information Services Office of Research Information Systems Office of Extramural Research /Office of the Director National Institutes of Health 6705 Rockledge Dr., Suite 4090, Room 4174 Bethesda, MD 20892 Office: 301-435-2696 Email: moorerf@mail.nih.gov Katrina Pearson Deputy Chief, Reporting Branch Division of Information Services Office of Research Information Systems Office of Extramural Research /Office of the Director National Institutes of Health 6705 Rockledge Dr., Suite 4090, Room 4168 Bethesda, MD 20892 Office: 301-435-2709 Email: pearsonk@mail.nih.gov Robin M. Wagner Chief, Reporting Branch Division of Information Services Office of Research Information Systems Office of Extramural Research /Office of the Director National Institutes of Health 6705 Rockledge Dr., Suite 4090, Room 4188 Bethesda, MD 20892 Office: 301-443-5234 Email: wagnerr@mail.nih.gov
Additional Resources • Award Information and Trend Data: http://report.nih.gov/award/award.cfm • Data Inquires: • Dishelp@mail.nih.gov • General Inquires: • GrantsInfo@mail.nih.gov • Application Submission: http://grants.nih.gov/grants/submitapplication.htm